CARMEN STEPHENS: Open Payments
NPI 1639952476 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 46 payments from 10 companies in 2025. Trend: 2023 $44 · 2024 $322 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $148 |
| Corium, LLC | 12 | $108 |
| Tris Pharma Inc | 4 | $67 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
Products named: VRAYLAR, Azstarys, Dyanavel XR, Jornay PM, AUSTEDO XR, Auvelity, REXULTI, Qelbree.
Industry payments across ID — which companies pay providers there.
